Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 4854
Gene Symbol: NOTCH3
NOTCH3
0.120 GeneticVariation disease CLINVAR
Entrez Id: 4854
Gene Symbol: NOTCH3
NOTCH3
0.120 CausalMutation disease CLINVAR
Entrez Id: 2878
Gene Symbol: GPX3
GPX3
0.010 Biomarker disease BEFREE 1996;97:979-987), plasma from 2 brothers with stroke or transient ischemic attack inactivated the antiplatelet effects of nitric oxide (NO), and this effect was found to be a consequence of a deficiency of plasma glutathione peroxidase (GSH-Px). 10446087 1999
Entrez Id: 4524
Gene Symbol: MTHFR
MTHFR
0.040 GeneticVariation disease BEFREE 677C to T mutation in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene and plasma homocyst(e)ine levels in patients with TIA or minor stroke. 9562260 1998
Entrez Id: 3163
Gene Symbol: HMOX2
HMOX2
0.010 Biomarker disease BEFREE Heme oxygenase-2 acts to prevent neuronal death in brain cultures and following transient cerebral ischemia. 10974422 2000
Entrez Id: 8936
Gene Symbol: WASF1
WASF1
0.010 GeneticVariation disease BEFREE WAVE system technology detected 16 variants in the RET gene in the 6 patients with TIA. 12632375 2003
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.020 GeneticVariation disease BEFREE ACE I/D genotypes were measured in 5688 of 6105 individuals with previous stroke or transient ischemic attack who participated in the PROGRESS trial. 12925557 2003
Entrez Id: 4312
Gene Symbol: MMP1
MMP1
0.010 Biomarker disease BEFREE MMP-1 and -12 transcript levels were significantly higher in plaques from patients with amaurosis fugax, than in those from asymptomatic patients (P=0.029 and P=0.008 for MMP-1 and MMP-12, respectively), than in those from patients with stroke (P=0.027 and P=0.001, respectively), and than in those from patients with transient ischemic attack (P=0.046 and P=0.008, respectively). 15073384 2004
Entrez Id: 2695
Gene Symbol: GIP
GIP
0.010 AlteredExpression disease BEFREE GIP receptor (GIPR) and OPN mRNA levels are higher in carotid endarterectomies from patients with symptoms (stroke, transient ischemic attacks, amaurosis fugax) than in asymptomatic patients, and expression associates with parameters that are characteristic of unstable and inflammatory plaques (increased lipid accumulation, macrophage infiltration, and reduced smooth muscle cell content). 26395740 2016
Entrez Id: 551
Gene Symbol: AVP
AVP
0.010 Biomarker disease BEFREE Copeptin seems to be a promising independent biomarker for predicting the functional outcome and all-cause mortality within 3 months or 1 year after acute ischemic stroke, and it could also be a powerful tool for early risk stratification for patients with transient ischemic attack. 27904159 2017
Entrez Id: 972
Gene Symbol: CD74
CD74
0.010 AlteredExpression disease BEFREE CD74-immunoreactive activated M1 microglia are shown late in the gerbil hippocampal CA1 region following transient cerebral ischemia. 28487994 2017
Entrez Id: 2932
Gene Symbol: GSK3B
GSK3B
0.020 Biomarker disease BEFREE GSK-3β as a target for protection against transient cerebral ischemia. 28553165 2017
Entrez Id: 213
Gene Symbol: ALB
ALB
0.010 AlteredExpression disease BEFREE Albumin expression may therefore be associated with ischemia‑induced delayed neuronal death in the CA1 region following transient cerebral ischemia. 28586018 2017
Entrez Id: 6505
Gene Symbol: SLC1A1
SLC1A1
0.010 GeneticVariation disease BEFREE EAAC1 gene deletion reduces adult hippocampal neurogenesis after transient cerebral ischemia. 29720605 2018
Entrez Id: 7132
Gene Symbol: TNFRSF1A
TNFRSF1A
0.010 AlteredExpression disease BEFREE TNF-R1 expression in CA1 pyramidal neurons of the TCI group was also increased 1 and 2 days after TCI; however, in the IPC + TCI group, TNF-R1 expression was significantly lower than that in the TCI group. 29777731 2018
Entrez Id: 55872
Gene Symbol: PBK
PBK
0.010 Biomarker disease BEFREE TOPK Promotes Microglia/Macrophage Polarization towards M2 Phenotype via Inhibition of HDAC1 and HDAC2 Activity after Transient Cerebral Ischemia. 29896413 2018
Entrez Id: 2309
Gene Symbol: FOXO3
FOXO3
0.010 AlteredExpression disease BEFREE FoxO3 transcription factor promotes autophagy after transient cerebral ischemia/reperfusion. 30595062 2019
Entrez Id: 4524
Gene Symbol: MTHFR
MTHFR
0.040 GeneticVariation disease BEFREE C677T MTHFR mutation and factor V Leiden mutation in patients with TIA/minor stroke: a case-control study. 9950259 1999
Entrez Id: 2147
Gene Symbol: F2
F2
0.010 GeneticVariation disease BEFREE A patient homozygous for mutation 20210A in the prothrombin gene with venous thrombosis and transient ischemic attacks of thrombotic origin. 9864932 1998
Entrez Id: 6647
Gene Symbol: SOD1
SOD1
0.300 Therapeutic disease CTD_human Activation of the Akt/GSK3beta signaling pathway mediates survival of vulnerable hippocampal neurons after transient global cerebral ischemia in rats. 16538228 2006
Entrez Id: 8864
Gene Symbol: PER2
PER2
0.020 GeneticVariation disease BEFREE Among these, 119 (83%) in period 1 and 114 (80%) in period 2 had final diagnosis of stroke or transient ischemic attack. 29402615 2018
Entrez Id: 348
Gene Symbol: APOE
APOE
0.020 GeneticVariation disease BEFREE ApoE alleles do not exert a major influence on the development of microbleeds, but apoE epsilon2 may be associated with development of moderate to severe white matter disease in transient ischemic attack and stroke patients. 17322072 2007
Entrez Id: 23468
Gene Symbol: CBX5
CBX5
0.010 Biomarker disease BEFREE Association of serum levels of antibodies against MMP1, CBX1, and CBX5 with transient ischemic attack and cerebral infarction. 29464021 2018
Entrez Id: 4524
Gene Symbol: MTHFR
MTHFR
0.040 GeneticVariation disease BEFREE Cerebral venous sinus thrombosis presenting as transient ischemic attacks in a case with homozygous mutations of MTHFR A1298C and CG677T. 20833086 2012
Entrez Id: 2717
Gene Symbol: GLA
GLA
0.010 AlteredExpression disease BEFREE Classically affected hemizygous males, with no residual α-galactosidase A activity may display all the characteristic neurological (pain), cutaneous (angiokeratoma), renal (proteinuria, kidney failure), cardiovascular (cardiomyopathy, arrhythmia), cochleo-vestibular and cerebrovascular (transient ischemic attacks, strokes) signs of the disease while heterozygous females have symptoms ranging from very mild to severe. 21092187 2010